Abstract
148 Effective treatment of acyclovir resistant genital herpes simplex virus infections with 2′Fluoro-Arabinosyl pyrimidine nucleosides: E.R. Kern 1, P.E. Vogt 1, J. Palmer 1, C.B. Hartline 1, and D.W. Adair 2. University of Alabama School of Medicine, Birmingham, AL; and Oclassen Pharmaceuticals, Inc., San Rafael, CA, USA
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
